evaxion.ai
Evaxion A/S is a leading TechBio company dedicated to transforming patient lives through innovative and targeted treatment options. Based in Hørsholm, Capital Region, Denmark, Evaxion operates from its primary address at Dr. Neergaards Vej 5F, Hørsholm, Capital Region 2970, DK.
At the heart of Evaxion A/S is its proprietary AI platform, AI-Immunology™. This cutting-edge, scalable AI prediction model harnesses the power of artificial intelligence to decode the human immune system. Evaxion leverages this technology to develop novel immunotherapies aimed at combating cancer, bacterial diseases, and viral infections. The company is focused on providing innovative healthcare solutions.
Evaxion has developed a robust clinical-stage oncology pipeline of personalized vaccines and a preclinical infectious disease pipeline targeting bacterial and viral diseases with high unmet medical needs. Evaxion A/S is committed to pushing the boundaries of biotechnology research and development, striving to create impactful advancements in the field. We invite the manager of Evaxion A/S to create a customized and exclusive company showcase and product listing on our platform.
Evaxion A/S er en førende TechBio-virksomhed, der er dedikeret til at transformere patienters liv gennem innovative og målrettede behandlingsmuligheder. Med base i Hørsholm, Region Hovedstaden, Danmark, opererer Evaxion fra sin primære adresse på Dr. Neergaards Vej 5F, Hørsholm, Region Hovedstaden 2970, DK.
Kernen i Evaxion A/S er dens proprietære AI-platform, AI-Immunology™. Denne banebrydende, skalerbare AI-forudsigelsesmodel udnytter kraften i kunstig intelligens til at afkode det menneskelige immunsystem. Evaxion udnytter denne teknologi til at udvikle nye immunoterapier, der er rettet mod bekæmpelse af kræft, bakterielle sygdomme og virusinfektioner. Virksomheden er fokuseret på at levere innovative sundhedsløsninger.
Evaxion har udviklet en robust klinisk-stadie onkologi-pipeline af personlige vacciner og en præklinisk infektiøs sygdoms-pipeline, der er rettet mod bakterielle og virussygdomme med høje udækkede medicinske behov. Evaxion A/S er engageret i at flytte grænserne for bioteknologisk forskning og udvikling og stræber efter at skabe virkningsfulde fremskridt inden for området. Vi inviterer lederen af Evaxion A/S til at oprette en skræddersyet og eksklusiv virksomhedsfremvisning og produktliste på vores platform.
Compare Evaxion A/S with 3 companies in Biotechnology-Research
| Comparison Field |
Evaxion A/SMain Company |
KariusView Profile |
AliveX BiotechView Profile |
Molecular IntellectView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2019 | 2025 |
|
Company Size
|
— | 51-200 | 51-200 | 2-10 |
|
City
|
Hørsholm, Capital Region | Redwood City, CA | Sydney, NSW | Raleigh-Durham, NC |
|
Country
|
Denmark | United States | Australia | |
|
Skills & Keywords
Comparing with main company
|
14 Total Skills
Biotechnology
Immunotherapy
AI-Immunology
Vaccines
Oncology
Infectious Diseases
Artificial Intelligence
Bioinformatics
AI
Immunoinformatics
Antigen Discovery
Neo Epitope Discovery
Immuno-Oncology
Biotech
|
13 Total
13 Unique
Unique Skills:
Cell-free DNA
Clinical care
Computational Biology
Data Science
Diagnostics
Genomics
+7
|
8 Total
8 Unique
Unique Skills:
Computational Biology
Diagnostics
Genomics
Immunology
MIDD
Multi-omics
+2
|
18 Total
1 Common
17 Unique
Match
7%
Common Skills:
Biotechnology
Unique Skills:
AlphaFold
Biology
Computational Biochemistry
Computational Biology
Computational Chemistry
Digital Health
+11
|
Other organizations in the same industry
This company is also known as